Sagewood Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Buy
2,635
+293
+13% +$297K 0.76% 21
2025
Q4
$2.52M Buy
+2,342
New +$2.24M 0.89% 23

Other funds holding LLY

Sagewood Asset Management's LLY Position: Q1 2026 in Review

Sagewood Asset Management increased its Eli Lilly (LLY) stake by 13% in Q1 2026, buying an estimated $297K and bringing the position to 2,635 shares worth $2.42M. The position accounts for 0.76% of the portfolio, ranked #21.

Sagewood Asset Management first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.52M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sagewood Asset Management held 2,635 shares of Eli Lilly worth $2.42M as of Q1 2026.
  • Sagewood Asset Management bought 293 Eli Lilly shares in Q1 2026, an estimated $297K.
  • Eli Lilly made up 0.76% of Sagewood Asset Management's portfolio in Q1 2026, its #21 holding.
  • Sagewood Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Sagewood Asset Management's Eli Lilly position peaked at $2.52M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sagewood Asset Management's 13F filing for Q1 2026, filed 13 May 2026.